+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Skin Cancer Treatment Market Analysis & Forecast 2024-2034: Market By Indication; By Therapy; By Distribution Channel; and By Region

  • PDF Icon

    Report

  • 145 Pages
  • October 2023
  • Region: Global
  • Erevna Healthcare
  • ID: 5890353
The global skin cancer treatment market size was estimated to be USD 10.73 billion in 2023 and is expected to reach at USD 26.65 billion by 2034 with a CAGR of 8.62% during the forecast period 2024-2034. Growing prevalence of skin cancer, rising awareness regarding the disease, increasing demand for skin cancer therapeutic products, surge in research & development activities, growing supportive initiative by government for rising awareness of skin cancer, rising drug approvals of innovative skin cancer therapeutics by regulatory agencies, and increasing launch of advanced treatment options are some of the key factors boosting the market growth.

Increasing launch of advanced treatment options is predicted to boost the market growth during the forecast period. A notable trend in the skin cancer treatment market involves the growing utilization of targeted and immunotherapy medications. Chemotherapy and radiation therapy are associated with several adverse effects. Consequently, there is a rising inclination among patients to select immunotherapy and targeted therapy medications. Moreover, targeted therapy drugs offer improved effectiveness in the treatment of skin cancer. For instance, in May 2022, Labcorp, a prominent worldwide life sciences firm, has introduced a novel assay designed to aid in determining suitable treatment choices for melanoma. This innovative test allows for the evaluation of Lymphocyte-activation gene 3 (LAG-3) expression levels through immunohistochemistry (IHC) analysis of tumor tissue. LAG-3 represents a target for immune-oncology and has shown tangible positive outcomes in treating melanoma patients. The assay is applicable for employment in both patient care and treatment as well as in clinical trial settings.

By indication, melanoma was the highest revenue-grossing segment in the global skin cancer treatment market in 2023 owing to rising prevalence of melanoma, increasing awareness regarding skin cancer among population, surge in technological advancement in the healthcare sector, and growing regulatory approvals. For instance, in January 2022, Immunocore has obtained United States Food and Drug Administration (FDA) clearance for KIMMTRAK (tebentafusp-tebn) to treat adult patients with unresectable or metastatic uveal melanoma (mUM) who are HLA-A*02:01-positive. Additionally, non-melanoma is predicted to grow at fastest CAGR during the forecast period owing to the increasing demand for surgical procedures & radiation therapy, surge in introduction of immunotherapy drugs against non-melanoma type of skin cancer, rising accessibility of therapeutic drugs for the treatment of non- melanoma, and growing research activities by key market players.

By therapy, immunotherapy was the highest revenue-grossing segment in the global skin cancer treatment market in 2023 owing to the efficacy of immunotherapy & a reduced risk of adverse effects, surge in number of product launches of immunotherapy drugs, and increasing approvals of novel immunotherapies by regulatory bodies. For instance, in March 2022, Nivolumab and Relatlimab-Rmbw (commercially known as Opdualag by Bristol-Myers Squibb Company) have gained the endorsement of the US FDA for treating unresectable or metastatic melanoma in patients aged 12 years and older, covering both adults and pediatric individuals. Additionally, radiation therapy is predicted to grow at fastest CAGR during the forecast period owing to the rising usage in treatment of squamous cell skin cancers and growing technological advancements in radiation therapy.

By distribution channel, hospital pharmacy was the highest revenue-grossing segment in the global skin cancer treatment market in 2023 owing to the ease of availability of drugs in hospital pharmacy and growing number of hospitals with hospital pharmacies. Additionally, online platforms is predicted to grow at fastest CAGR during the forecast period owing to the increasing adoption of online platforms for buying pharmaceuticals, a rise in public awareness of these platforms, and growing initiatives by leading market players. For instance, in January 2022, SkinCure Oncology has directed its attention toward establishing a comprehensive approach to delivering Image-Guided Superficial Radiotherapy (Image-Guided SRT). They have introduced GentleCure.com, a platform dedicated to consumer health education, which presents well-founded treatment choices for basal cell (BCC) and squamous cell skin cancers (SCC).

North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of skin cancers, surge in improved healthcare infrastructure, rising advancements in skin cancer therapy for developing innovative therapies, increasing demand for development of advanced therapeutics, growing research & development (R&D) activities for cancer therapeutics, and surge in launch of advanced units by market players. For instance, in April 2022, barnaclà¬nic+ has inaugurated its Dermatological Diagnosis Unit, specializing in the diagnosis and therapy of skin cancer. This newly established unit is equipped with state-of-the-art dermatological diagnostic technology for the diagnosis of skin cancer. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in initiative taken by government to develop healthcare infrastructure, growing awareness among people regarding availability of skin care treatments, increase in number of population suffering from melanoma, and rising research & development activities. For instance, in December 2022, Sirnaomics Ltd. has unveiled the interim findings from the initial segment of an ongoing Phase IIb clinical study involving STP705, intended for addressing Cutaneous Squamous Cell Carcinoma In Situ (isSCC). Encouraging clinical outcomes were observed in the preliminary phase of this Phase IIb trial for the compound.

Segmentation: Skin Cancer Treatment Market Report 2022 - 2033

Skin Cancer Treatment Market Analysis & Forecast by Indication 2023 - 2034 (Revenue USD Bn)

  • Melanoma
  • Non-melanoma

Skin Cancer Treatment Market Analysis & Forecast by Therapy 2023 - 2034 (Revenue USD Bn)

  • Immunotherapy
  • Targeted Therapy
  • Chemotherapy
  • Radiation Therapy

Skin Cancer Treatment Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Platforms
  • Others

Skin Cancer Treatment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Skin Cancer Treatment Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Skin Cancer Treatment Market: Indication Estimates & Trend Analysis
7.1. Indication Segment Opportunity Analysis
7.2. Melanoma
7.2.1. Melanoma Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Non-melanoma
7.3.1. Non-melanoma Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Skin Cancer Treatment Market: Therapy Estimates & Trend Analysis
8.1. Therapy Segment Opportunity Analysis
8.2. Immunotherapy
8.2.1. Immunotherapy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Targeted Therapy
8.3.1. Targeted Therapy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Chemotherapy
8.4.1. Chemotherapy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Radiation Therapy
8.5.1. Radiation Therapy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Skin Cancer Treatment Market: Distribution Channel Estimates & Trend Analysis
9.1. Distribution Channel Segment Opportunity Analysis
9.2. Retail Pharmacy
9.2.1. Retail Pharmacy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Hospital Pharmacy
9.3.1. Hospital Pharmacy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Online Platforms
9.4.1. Online Platforms Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.5. Others
9.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Skin Cancer Treatment Market
11.1. North America Skin Cancer Treatment Market
11.1.1. North America Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Skin Cancer Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.1.4. North America Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
11.1.5. North America Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Skin Cancer Treatment Market
11.2.1. U.S. Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Skin Cancer Treatment Market
11.3.1. Canada Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12. Europe Global Skin Cancer Treatment Market
12.1. Europe Global Skin Cancer Treatment Market
12.1.1. Europe Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Skin Cancer Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Skin Cancer Treatment Market
12.2.1. Germany Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. UK Global Skin Cancer Treatment Market
12.3.1. UK Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.3.3. UK Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
12.3.4. UK Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.4. France Global Skin Cancer Treatment Market
12.4.1. France Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.4.3. France Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
12.4.4. France Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Skin Cancer Treatment Market
12.5.1. Spain Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Skin Cancer Treatment Market
12.6.1. Italy Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Skin Cancer Treatment Market
12.7.1. Rest of Europe Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Skin Cancer Treatment Market
13.1. Asia Pacific Global Skin Cancer Treatment Market
13.1.1. Asia Pacific Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Skin Cancer Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Skin Cancer Treatment Market
13.2.1. Japan Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. China Global Skin Cancer Treatment Market
13.3.1. China Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.3.3. China Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
13.3.4. China Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. India Global Skin Cancer Treatment Market
13.4.1. India Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.4.3. India Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
13.4.4. India Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Skin Cancer Treatment Market
13.5.1. South Korea Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Skin Cancer Treatment Market
13.6.1. Australia Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Skin Cancer Treatment Market
13.7.1. Rest of Asia Pacific Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. Latin America Global Skin Cancer Treatment Market
14.1. Latin America Global Skin Cancer Treatment Market
14.1.1. Latin America Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Skin Cancer Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Skin Cancer Treatment Market
14.2.1. Brazil Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Skin Cancer Treatment Market
14.3.1. Mexico Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Skin Cancer Treatment Market
14.4.1. Argentina Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Skin Cancer Treatment Market
14.5.1. Rest of Latin America Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. MEA Global Skin Cancer Treatment Market
15.1. MEA Global Skin Cancer Treatment Market
15.1.1. MEA Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Skin Cancer Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Skin Cancer Treatment Market
15.2.1. GCC Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Skin Cancer Treatment Market
15.3.1. South Africa Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Skin Cancer Treatment Market
15.4.1. Rest of MEA Skin Cancer Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Skin Cancer Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Skin Cancer Treatment Market Size and Forecast, By Therapy, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Skin Cancer Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. LEO Pharma
17.2. Merck KGaA
17.3. Sun Pharmaceutical Industries Ltd.
17.4. Bristol-Myers Squibb
17.5. Novartis AG
17.6. Amgen Inc.
17.7. F. Hoffmann-La Roche
17.8. Pfizer Inc.
17.9. GlaxoSmithKline plc
17.10. Regeneron Pharmaceuticals, Inc.
17.11. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • LEO Pharma
  • Merck KGaA
  • Sun Pharmaceutical Industries Ltd.
  • Bristol-Myers Squibb
  • Novartis AG
  • Amgen Inc.
  • F. Hoffmann-La Roche
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Regeneron Pharmaceuticals Inc.

Table Information